


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.  Description and Sources of Human Exposure to 41 Priority Hazardous Air Pollutants 1 
 


















UATS Ubiquitous organic, used in 
synthesis of chemicals.  
Byproduct of ethanol 
metabolism.  Incomplete 
combustion of organics, such 
as from residential fireplaces,  
industry, or vehicles. 





UATS Intermediate in manufacture 
of acrylic acid.  Breakdown 
product of other air pollutants 
or from burning tobacco, 
gasoline, or coal (vehicles 
and power plants). 
X X None 
Acrylonitrile  
 
• VOC UATS Release from manufacture of 
plastics. 























UATS Naturally occurring metal 
found throughout the 
environment.  Metal smelters.  
Pesticide application. Coal 
and wood combustion.  
Burning plywood treated with 
arsenic wood preservative. 
 X Food is the primary 
human exposure 




Grains and produce 
contain inorganic 






UATS Constituent of motor fuels 
and a solvent.  Burning coal 
and oil.  Motor vehicle 
exhaust.  Industrial solvent 
evaporation.  Tobacco 
smoke. 









UATS Metal found in some rocks, 
coal, oil, and soil, used as 
structural component in 
aircraft and consumer 
products.  Burning of coal or 
oil.  Tobacco smoke. 




















• VOC UATS Used in production or rubber, 
plastics, and acrylics.  Motor 
vehicle exhaust.  Forest fires.  
Manufacturing (oil refineries 
and chemical)  Tobacco 
smoke. 









UATS Burning of fossil fuels (coal, 
oil, municipal waste).  Power 
plants, waste incinerators, 
metal smelters.  Tobacco 
smoke. 
X X Bioaccumulates; 
expect food and 
water exposures.5  
Food (vegeTables) 






UATS Used as a refrigerant, aerosol 
propellant, or solvent.  
Releases from production, 
disposal in landfills, and 
leaches from consumer 
products. 







UATS Released into air from 
chlorination of drinking water, 
wastewater, and swimming 
pools.  Pulp and paper mills.  
Hazardous waste sites. 




























UATS Essential nutrient. Steel and 
alloy manufacture.  Coal and 
oil combustion.   Chrome 
plating, pigments, and 
multiple industrial uses. 
X X Food (naturally 
occurring in produce, 











UATS Coal is used to produce coke, 
component of iron and steel.  
Aluminum, steel, graphite, 
electrical, and construction 
industry releases.   






UATS Used as agricultural soil 
fumigant.  Releases from 
manufacture, storage, 
transport, and disposal. 
Byproduct of water 
disinfection. 







VE Vehicle emissions, especially 
large trucks. 























VE Used in production of styrene, 
as solvent, in cleaning 
products, in fuels.  Exposure 
from use of consumer 
products, burning oil or coal, 
vehicle emissions, tobacco 
smoke. 
X X Indoor air may be a 
substantial source 






• VOC UATS Environmental accumulation 
from past use in leaded 
gasoline and as fumigant.  
Several current industrial 
uses. 
  Water ingestion 
(groundwater 








UATS Multiple industrial uses:  
plastic manufacture, solvent, 
lead scavenger, dispersant, 
degreaser, fumigant.  
Widespread release from 
production, storage, use, 
transport, and disposal. 




















• VOC UATS Industrial chemical 
intermediary.  Widespread 
industrial emissions.  Vehicle 
exhaust, sterilization of 
medical equipment. Tobacco 
smoke. 





UATS Used in particleboard, 
disinfectants, photography, 
preservative, and as chemical 
intermediary.  Byproduct of 
combustion. 










UATS No direct uses, but formed as 
an industrial byproduct in 
solvent and pesticide 
manufacture.  Industrial or 
waste facility emissions. 
  Bioaccumulates; 




• VOC VE Used to extract edible oils, as 
a solvent, and cleaning agent.  
Vehicle exhaust. 




















• VOC UATS Used in pesticides and many 
other products.  Exposure 
from storage, handling, 
transport, disposal.  Tobacco 
smoke. 








UATS Battery manufacture, other 
products.  Combustion of 
waste, coal, oil, iron.  
Emissions from iron and steel 
production.  Tobacco smoke. 
 X Bioaccumulates; 
expect food and 
water exposures.5  
House dust in old 










UATS Essential nutrient.  Naturally-
occurring.  Iron and steel 
production, power plants, 
coke ovens.  Gasoline 
additive (vehicle exhaust). 
X X Bioaccumulates; 
expect food and 








UATS Elemental mercury used in 
thermometers, batteries, 
dental amalgams.  Mercuric 
chloride used as disinfectant 
and pesticide. 
  Bioaccumulates; 
expect food and 

























UATS Used as a solvent, propellant, 
and grain fumigant. 
  Concentrates indoors 
(Payne-Sturges, 
Burke et al. 2004). 
Methyl tert-butyl 
ether (MTBE) 
•  VE Gasoline additive.  Motor 
vehicle exhaust. 








UATS Used in batteries, machine 
parts.  Oil and coal 
combustion, sewage sludge 
incineration. 
X X Food. 
Polycyclic Aromatic 
Hydrocarbons Group 





• Subset of 
POM 
UATS Cigarette smoke, vehicle 
exhaust, residential wood 
burning, waste incineration, 
other combustion sources. 
X  Bioaccumulates; 
expect food and 
water exposures.5  









UATS Used in drycleaning and 
metal degreasing.  Releases 
from use, transport, storage, 
and disposal. 






















• Mixture of 
congeners 
UATS Current use is banned, but 
releases from soil, water, old 
electrical appliances, disposal 
sites. 
  Bioaccumulates; 
expect food and 
water exposures.5  
Fish consumption. 
Polycyclic Organic 




• Mixture  
• Includes 
PAH-7 
UATS Broad chemical group 
including PAHs and oxygen-
containing polycyclic organic 
matter.  Cigarette smoke, 
vehicle exhaust, other 
combustion sources. 
 
X  Bioaccumulates; 






VE Used in manufacture of 
plastic, as disinfectant and 
preservative.  Releases from 
industry and from combustion 
of wood, gasoline, municipal 
waste.  Vehicle emissions. 

























UATS Industrial chemical 
intermediate, solvent, past 
use in soil fumigation and as 
a pesticide.  Releases from 
manufacture, use, storage, 
disposal. 
  None 
Quinoline 
 
•  UATS Industrial chemical 
intermediate. Emissions from 
petroleum refining, coal 
mining, other organic 
processing. Tobacco smoke. 






VE Used in production of plastics 
and resins.  Release from 
industry and building 
materials.  Vehicle exhaust. 












UATS Industrial chemical 
intermediate.  Fugitive 
emissions and discharges 
from industry. 























VE Component of gasoline.  
Motor vehicle exhaust.  Many 
industrial uses.  Tobacco 
smoke. 
X  Concentrates indoors 
(Payne-Sturges, 







UATS Release from industrial 
degreasing.  Used as solvent, 
chemical intermediate, 
refrigerant.  Releases from 
manufacture, use, storage, 
disposal. 











UATS Manufacture polyvinyl 
chloride (PVC).  Industrial 
discharges. 






VE Component of gasoline.  
Motor vehicle exhaust.  
Fugitive emissions from 
industrial sources (used as 
solvent). 





1. Information obtained from (Environmental Protection Agency 20063), an EPA report on Highway Mobile Sources (Cook, Driver et al. 
2002) and ATSDR Toxicologic Profiles (Agency for Toxic Substances and Disease Registry various years). 
2. VOC is volatile organic compound.  SVOC is semi-volatile organic compound.  Thanks to Kenneth Mitchell, Chief, Air Toxics and 
Implementation Section, US EPA Region 4, for chemical descriptions. 
3. These 41 HAPs were identified as priority pollutants by the Urban Air Toxics Strategy (UATS) or by the EPA air modeling group 
because they are found in vehicle emissions (VE). 
4. Only sources of human exposure that are substantial in comparison to outdoor air exposure are listed in this column.  Almost all 
chemicals will be found at the highest levels in an occupational setting.  Occupational settings are not included in my consideration of 
general population exposures. 
5. Certain HAPs are known to have persistent bioaccumulation potential, so that they will end up in the food and water supply chain.  
Obtained from Exhibit 1 in Appendix D in (Mitchell, Smith et al. 2004). 
6. Coke oven emissions includes POM, PAH, benzene, arsenic, beryllium, cadmium, chromium, lead, nickel 
7. The 7-PAH group includes 7 chemical species: Benz[a]anthracene, Benzo[b]fluoranthene, Benzo[k]fluoranthene, Benzo[a]pyrene, 
Chrysene, Dibenz[a,h]anthracene, and Indeno[1,2,3-cd]pyrene. The 7-PAH are a subset of 16-PAH (16-PAH is referred to as 





































































































Term Description Emissions Data Source 
Point Point sources of air pollution are large, 
unique sources that are positioned at a 
specific map location.  These are usually 
manufacturing facilities such as chemical 
production plants or waste incinerators. 
The Toxics Release Inventory of the EPA, an 
annual compilation of facility-reported 
estimates of releases and transfers for over 
300 pollutants, and other EPA national 
emissions inventories. 
Area Area sources are smaller-scale dispersed 
emitters that tend to repeat across the 
US.  They are not uniquely positioned on 
a map, but are estimated to co-occur with 
population density and with the use of the 
land, and include gas stations, dry 
cleaners, wild fires, combustion, 
consumer product use, and agriculture.   
Area sources are estimated from information 
on HAPs emissions from different entities 
(process-specific speciation profiles) and how 
often such entities are located by population 
density, residential versus commercial land, 
farmland, etc. 
Mobile Mobile sources are vehicles, categorized 
as on-road (cars and trucks) and non-
road (planes and boats). 
Mobile source emissions can be estimated 
from interstate and road data, traffic density 

































































































































































































































Damage to the 
Developing 
Nervous System 












  Identified in Previous 
Autism Studies 

















No ATSDR Tox 
Profile.  (Takeuchi 
and Saito 2005) 
(Masaki, 
Mochizuki et al. 
2004) 
 NE3 YES                 
May be responsible for 








(Lovell, Xie et al. 
2001) (Butterfield, 
Castegna et al. 
2002) 
 NE3 YES            
Acrolein is a product of 
lipid peroxidation in the 
human body, involved 
with oxidative stress, 
may be involved in 
neurodegeneration 
found in Alzheimer’s 
disease 
YES     
Inflammatory 
responses in 








  Identified in Previous 
Autism Studies 


















Profile (1990)  
 NE3 YES      
Degenerative changes 
in animal brain cells 
after inhalation. 






Arsenic Compounds  ATSDR Tox 
Profile (2005) 
(Tsai, Chou et al. 
2003) 
(Wasserman, Liu 
et al. 2004) 
(Clarkson 1987) 
X X YES           
Inorganic arsenic 
(inhaled or ingested) 
caused peripheral 
neuropathy in humans.  
Ingested exposure 
during childhood may 
have determintal effects 
on IQ. 










  Identified in Previous 
Autism Studies 








































 NE3 UNKNOWN YES 
Immunologic 


















  Identified in Previous 
Autism Studies 




















X X YES 
Prenatal animal 
exposure impaired 






X X YES 
Depression of the CNS5 
after acute inhaled 







X X YES 
Depression and 









oral exposure.  
Immune system 







  Identified in Previous 
Autism Studies 









































  Identified in Previous 
Autism Studies 


















(Laurie and Boyes 
1980), (Laurie and 
Boyes 1981) 
  YES 
Chronic diesel exhaust 
exposure in rats during 
early postnatal life were 
shown to have 
detrimental effects on 
motor activity and 



























 X YES 
Animal paternal inhaled 
exposure caused brain 
and behavior changes 





  Identified in Previous 
Autism Studies 




















 X YES 
Effects on the nervous 
system after chronic 
ingestion or inhalation 
in animals. 
YES 










 NE3 YES 
Chronic occupational 
exposure led to 










 NE3 YES 
Decreased 
performance for 
memory, motor speed, 
cognitive function in 












  Identified in Previous 
Autism Studies 



















 X YES 
Neurological problems 















 NE3 YES 
Chonic human inhaled 
exposure associated 
with polyneuropathy 






 X YES 
Human inhaled 
exposure associated 








  Identified in Previous 
Autism Studies 




















X X YES 
Substantial evidence of 
human developmental 
neurotoxicity after 

















(Pihl and Parkes 
1977), (Collipp, 
Chen et al. 1983) 
(Clarkson 1987) 
 X YES 
Human chronic inhaled 

























  Identified in Previous 
Autism Studies 




















X X YES 
Nervous system is a 









 NE3 YES 
CNS5 effects in animals 

















  Identified in Previous 
Autism Studies 





















(Perera, Rauh et 
al. 2006) 
X X YES 
Human maternal 
inhaled exposure was 
associated with 
reduced cognitive 

















X X YES 
Neurological (motor 
and cognitive) effects 








X X YES 
Human studies with 
ingested maternal 
exposure (fish) suggest 
motor and cognitive 












  Identified in Previous 
Autism Studies 




















Profile for PAH 
(1995) 
X NE3 See PAH-7 See PAH-7 See PAH-7 
Propionaldehyde 
 









 NE3 YES 
Animal CNS5 effects 













  Identified in Previous 
Autism Studies 



















 X YES 
Chronic human inhaled 
exposure associated 












 NE3 YES 
Chronic human 
exposure associated 









X  YES 
CNS5 effects after 
chronic inhalation in 















  Identified in Previous 
Autism Studies 




















X X YES 
Chronic human 
inhalation associated 















X X YES 
Central and peripheral 















X  YES 
















1. For all chemicals, toxicological information was obtained from the EPA website, “Health Effects Notebook for Hazardous Air 
Pollutants”  (Environmental Protection Agency 20063), “Scorecard Air Pollution Information Site” (Green Media Toolshed)  ATSDR 
Toxicological Profiles with years as noted (Agency for Toxic Substances and Disease Registry various years), and published literature 
as noted. 
2. Indicated HAPs were identified as environmental toxicants of concern during a literature review by the ATSDR Brick Township 
investigation of autism (Agency for Toxic Substances and Disease Registry 1998). 
3. Indicated HAPs were part of an exposure index found to have an odds ratio > 1.3 in a study of HAPs and autism in California 
(Windham, Zhang et al. 2006).  Index groups included metals, chlorinated solvents, and suspected endocrine toxicants.  NE indicates 
a HAP that was not evaluated in this study.  Only 3 evaluated HAPs were not part of a group with an elevated odds ratio:  diesel 
particulate matter, toluene, and xylenes. 
4. A HAP was noted as neurotoxic or immunotoxic if any information source designated it as such. 
5. CNS:  central nervous system. 
6. Placental transfer.  Indicates that placental transfer was not assessed directly, but was inferred from perinatal impairments resulting 
from maternal inhaled or ingested exposure. 
7. Although details were not available, this chemical was listed as a neurotoxicant or immunotoxicant in lists such as “Haz-Map” 













































































































































State  Description of Surveillance Area  2000  2002  2004 
WV  entire state  X X 
NC 
8‐county area in the center of the state 












































































































































Figure 3.  Process and Numbers of Children in NC-ADDM Surveillance for Study 
Year 2002 
 




(N = 135) 
Met “triggers” for record 
abstraction 
(N = 369, 11%) 
• Born in 1994 
• Reside in study counties in 2002 
• Indication of developmental problem: 
o Attended public schools and had an 
exceptionality code, including speech 
and language impairment 
o Any record at TEACCH 
o ICD-9 of concern at CDSA 
 
(N = 3846)
Record not located 
(n = 506, 13%) 
No “triggers” 
(N = 2971, 89%) 
Abbreviations: 
TEACCH:  Division of Treatment and Education of Autistic and related Communication handicapped CHildren 
ICD-9:  International Classification of Diseases 
CDSA:  Child Development Service Agencies 
ASD:  Autism Spectrum Disorder 
Suspected ASD 
(N = 142) 
No ASD 




































































































































































































































































































































TEACCH:  Division for the Treatment and Education of Autistic and related Communication-handicapped 
CHildren 
CDSA:  Children’s Developmental Services Agency 
HPDS:  North Carolina Health Professions Data System 
HPSA:  Health Professional Shortage Area 

















































































































































































































































































































































































        OR (HAP and autism) 






        OR (HAP and autism)       




























































































































































































































































































Compared to Health 
Benchmark5 
Hazardous Air 


















Acetaldehyde 5.6E-01 6.8E-01 5.1E-01  0.8 3  2.8E+02 62 High 9 0 
Acrolein 9.2E-02 1.1E-01 6.8E-02  0.6 2  4.4E+00 57 High 0.02 99.8 
Acrylonitrile 4.4E-04 1.4E-03 6.6E-03 X 4.8 7 High 1.6E-03 2  2 0 
Arsenic Compounds 8.8E-05 3.8E-04 4.0E-03  10.5 5 High 2.2E-04 1  0.03 0.2 
Benzene  1.1E+00 1.4E+00 8.0E-01  0.6 2  5.5E+02 51 High 60 0 
Beryllium 



















Compared to Health 
Benchmark5 
Hazardous Air 


















1,3-Butadiene 5.4E-02 7.3E-02 6.9E-02  1.0 4  2.6E+00 32  8 0 
Cadmium 




Tetrachloride 8.8E-01 8.8E-01 1.0E-03 X 0.0 1 Low 1.7E-04 10  
2.4 
0 
Chloroform  8.5E-02 8.6E-02 6.8E-03  0.1 1 Low 5.4E-03 7  35 0 
Chromium 























Compared to Health 
Benchmark5 
Hazardous Air 


















1,3-Dichloropropene 5.1E-02 8.3E-02 9.8E-02  1.2 6  7.5E+00 46  20 0 
Diesel Particulate 
Matter 1.6E+00 2.0E+00 1.4E+00  0.7 3  1.5E+03 44  
None 
 
Ethylbenzene 2.9E-01 3.9E-01 3.7E-01  0.9 5  1.1E+02 50  1000 0 
Ethylene Dibromide  7.7E-03 7.7E-03 1.1E-05 X 0.0 1 Low 5.3E-09 3  0.2 0 
Ethylene Dichloride 6.1E-02 6.1E-02 1.6E-04 X 0.0 1 Low 8.2E-06 19  0.04 100 
Ethylene Oxide 2.4E-03 5.8E-03 1.2E-02  2.1 14 High 9.7E-03 4  5 0 
Formaldehyde  9.0E-01 1.1E+00 7.1E-01  0.6 2  5.3E+02 62 High 3.6 0.7 

















Compared to Health 
Benchmark5 
Hazardous Air 


















Hexane 3.9E-01 5.7E-01 6.2E-01  1.1 4  2.0E+02 31  200 0 
Hydrazine 6.0E-08 1.0E-06 1.6E-05 X 15.2 30 High 2.3E-09 1  0.2 0 
Lead Compounds 1.7E-03 2.7E-03 3.3E-03  1.2 9 High 3.9E-03 21  1.5 0 
Manganese 
Compounds 2.1E-03 4.3E-03 9.2E-03  2.1 8 High 5.2E-03 4  
0.05 
0.5 
Mercury Compounds 2.2E-04 4.4E-04 7.6E-04  1.7 7 High 3.1E-04 32  
0.3 
0 
Methylene Chloride 3.1E-01 4.3E-01 3.9E-01  0.9 3  6.1E+01 24  3000 0 
Methyl tert-butyl 



















Compared to Health 
Benchmark5 
Hazardous Air 


















Nickel Compounds 8.1E-04 3.7E-03 2.1E-02  5.6 9 High 9.6E-03 1  0.05 1 
Polycyclic Aromatic 
Hydrocarbons Group 
7 (PAH7) 2.8E-03 4.6E-03 1.7E-02  3.6 4 High 1.5E-02 3  None NA 
Perchloroethylene 
(Tetrachloroethylene) 








Matter (POM) 5.9E-02 7.6E-02 7.8E-02  1.0 5  1.8E+00 18  
100 
0 

















Compared to Health 
Benchmark5 
Hazardous Air 


















Propylene Dichloride 2.5E-05 4.5E-05 6.8E-05 X 1.5 6  1.2E-06 16  4 0 
Quinoline 5.4E-07 2.2E-05 1.2E-04 X 5.7 15 High 1.59E-06 6  None NA 
Styrene 2.6E-02 4.5E-02 8.1E-02  1.8 6  6.4E-01 6  1000 0 
1,1,2,2-
Tetrachloroethane 1.7E-04 3.3E-04 5.1E-04 X 1.5 6  8.0E-05 19  3000 0 
Toluene 1.9E+00 2.6E+00 2.4E+00  0.9 5  4.5E+03 45  400 0 
Trichloroethylene 1.1E-01 1.2E-01 6.0E-02  0.5 2  9.0E-01 15  600 0 
Vinyl Chloride 5.5E-04 1.6E-03 5.6E-03 X 3.4 7 High 1.0E-03 2  26 0 





Table 12 Notes: 
1. Abbreviations:  ug/m3 – micrograms of pollutant per cubic meter of outdoor air; Std – standard deviation; SSM – sum of squares 
explained by the model; SST – total sum of squares; NA – not applicable. 
2. HAP estimates are from NATA-1996.  All values refer to the census tracts included in ADDM autism surveillance from MD, WV, 
NC, and SC, using the census tract as the unit of analysis. 
3. To determine how variability in the study area compared to variability in the US, I created a ratio between the standard deviation in 
the study census tracts as a percentage of the standard deviation for all census tracts in the contiguous US. 
4. Between state variability was assessed using an ANOVA with state as the explanatory variable. 
5. Health effect levels have been evaluated by comparing to benchmark levels.  Benchmark values represent a presumptive health 
protective level for long-term exposure and non-cancer endpoints with an ample margin of safety, as determined from multiple 
studies (Caldwell, Woodruff et al. 1998).  Benchmark concentrations are levels that represent potential thresholds of concern; 
levels below the benchmark presumptively are not associated with adverse health effects.  Benchmarks can only be established 
when studies describing the dose response for health endpoints of interest are available.  Different regulatory bodies compile and 
evaluate evidence from such studies.  Ambient air benchmark values for chronic inhaled exposure and non-cancer endpoints have 
been assembled for most of the priority HAPs (Caldwell, Woodruff et al. 1998).  The benchmarks for chronic non-cancer 
endpoints, were from the following sources, in order of priority: 
• Inhalation Reference Concentration of the US EPA (RfC), of a daily exposure to the human population, including sensitive 
subgroups, likely to be without appreciable risk of deleterious effects during a lifetime. 
• Reference Exposure Levels (RELs) of long-term inhalation toxicity used by the California Air Toxics Program. 
• Minimal Risk Levels (MRLs) developed by the Agency for Toxic Substances and Disease Registry, representing the maximum 







































































































































































































































































































































































































































































































































































































































        Autism diagnosis 
        None  % Late  % Early 
    n= (> 52 m)  (<=52 m)
Child Characteristics             
Sex  Female  27 22% 44%  33%
  Male  179 23% 36%  40%
Race  Non‐Hispanic White 118 22% 37%  41%
  Non‐Hispanic Black 75 24% 39%  37%
  Other  12 33% 25%  42%
Developmental loss or 
plateau 
No  160 28% 43%  29%
  Yes  46 9% 17%  74%
Intellectual Disabilities 
(Intelligence Quotient) 
None (71‐ ) 104 28% 41%  31%
  Mild/moderate 
impairment (35‐70) 
62 21% 44%  35%
  Severe impairment 
(< 35) 
34 12% 15%  74%
Degree of impairment  Mild  137 28% 39%  34%




        Autism diagnosis 
        None  % Late  % Early 
    n= (> 52 m)  (<=52 m)
Maternal education  < High school 30 40% 37%  23%
  High school degree 104 25% 38%  38%
  College degree 71 14% 38%  48%
Married  No  60 30% 43%  27%
  Yes  146 21% 35%  45%
Maternal age (years)  22 or younger 37 41% 30%  30%
  23‐34  141 22% 38%  40%
  35 or older 28 7% 43%  50%
Prenatal care begun in 
1st trimester 
No  24 21% 50%  29%
  Yes  182 24% 36%  41%
Moved  No  85 28% 34%  38%
  Yes  121 20% 40%  41%
Median household 
income ($/year) 
<= $30,000 50 34% 36%  30%
  $30,000<=$40,000 45 18% 38%  44%
  $40,000<=$50,000 52 25% 37%  38%
  $50,000<=$60,000 34 21% 26%  53%













%None %Late %Early    Months Unadjusted Adjusted1
n= (>52 m) (<=52 m)    n=203 n=196
Number within 20 miles               
Primary care physicians  13 < 100  34 26% 32% 41%   58 (50, 89) Ref Ref
100 ‐ 600  172 23% 38% 39%   63 (55, 74) 1.1 (0.7, 1.7) 1.0 (0.6, 1.7)
Specialist physicians  0 < 100  93 31% 37% 32%   70 (55, 85) Ref Ref
100 ‐ 424  113 17% 38% 45%   60 (49, 77) 1.4 (1.0, 1.9) 1.2 (0.8, 1.7)
Psychologists  1 < 100  131 26% 35% 39%   65 (53, 77) Ref Ref
100 ‐ 484  75 19% 41% 40%   62 (52, 81) 1.1 (0.8, 1.6) 0.9 (0.6, 1.3)
Distance to the nearest             











%None %Late %Early    Months Unadjusted Adjusted1
n= (>52 m) (<=52 m)    n=203 n=196
< 4 miles  186 23% 38% 39%   63 (54, 75) 1.0 (0.6, 1.8) 0.8 (0.4, 1.6)
Specialist physician  4 ‐ 21 miles 43 14% 44% 42%   58 (48, 77) Ref Ref
< 4 miles  163 26% 36% 39%   64 (55, 79) 0.7 (0.5, 1.1) 0.6 (0.4, 1.0)
Psychologist  4 ‐ 19 miles 49 14% 39% 47%   53 (47, 77) Ref Ref
< 4 miles  157 26% 37% 37%   70 (56, 79) 0.7 (0.5, 1.0) 0.6 (0.3, 1.0)
TEACCH  20 ‐ 101 miles 68 19% 37% 44%   62 (49, 81) Ref Ref
< 20 miles 138 25% 38% 37%   63 (55, 77) 0.9 (0.6, 1.3) 0.8 (0.6, 1.2)
CDSA  20 ‐ 41 miles 38 32% 29% 39%   60 (49, 94) Ref Ref
< 20 miles 168 21% 39% 39%   64 (55, 74) 1.2 (0.8, 1.9) 1.4 (0.8, 2.3)
Teaching hospital  20 ‐ 90 miles 92 33% 37% 30%   73 (58, 89) Ref Ref











%None %Late %Early    Months Unadjusted Adjusted1
n= (>52 m) (<=52 m)    n=203 n=196
Residence within a             
HPSA  Yes  27 41% 30% 30%   73 (53, NE3) Ref Ref
No  179 21% 39% 41%   62 (54, 74) 1.6 (1.0, 2.8) 1.4 (0.8, 2.5)
Urban area  No  71 18% 48% 34%   74 (54, 85)













  Developmental Loss or Plateau    Degree of Impairment4    Residence in an Urban Area 
  No (n=154)  Yes (n=42)    Mild (n=105)  Mod/Severe (n=68)    Not Urban (n=66)  Urban (n=130) 




                           
0 < 100  25/69  Ref  3/22  1.5 (0.8, 3.1)    24/48  Ref  4/32  3.3 (1.8, 6.1)    5/35  Ref  23/55  0.6 (0.4, 1.2) 
100 ‐ 424  17/87  1.1 (0.7, 1.7)  1/20  3.9 (2.1, 7.3)    12/57  1.7 (1.0, 2.9)  6/36  2.9 (1.6, 5.5)    8/31  0.6 (0.4, 1.1)  10/75  1.2 (0.7, 1.9) 
RERI (95% CL)  2.3 (0.1, 4.4)    ‐1.0 (‐3.1, 1.1)    0.9 (0.4, 1.4) 
                             
Distance to nearest 
teaching hospital  
                           
20 ‐ 90 miles  26/69  Ref  3/21  1.6 (0.8, 3.2)    25/49  Ref  4/31  3.3 (1.8, 6.0)    6/35  Ref  23/54  0.7 (0.4, 1.2) 
< 20 miles  16/87  1.2 (0.8, 1.8)  1/21  3.9 (2.1, 57.3)    11/56  1.7 (1.0, 3.0)  6/37  3.1 (1.6, 5.7)    7/31  0.7 (0.4, 1.3)  10/76  1.2 (0.8, 2.0) 
RERI (95% CL)  2.1 (0.0, 4.3)    ‐0.9 (‐.3.0, 1.2)    0.9 (0.4, 1.4) 
                             
Distance to nearest 
CDSA  
                           




  Developmental Loss or Plateau    Degree of Impairment4    Residence in an Urban Area 
  No (n=154)  Yes (n=42)    Mild (n=105)  Mod/Severe (n=68)    Not Urban (n=66)  Urban (n=130) 
  N2/N3  HR (CL)  N2/N3  HR (CL)    N2/N3  HR (CL)  N2/N3  HR (CL)    N2/N3  HR (CL)  N2/N3  HR (CL) 
< 20 miles  32/128  1.0 (0.6, 1.9)  2/34  3.5 (1.6, 7.4)    25/86  2.0 (0.8, 4.9)  9/55  4.2 (1.7, 10.8)    8/46  1.1 (0.6, 2.2)  26/114  1.4 (0.8, 2.5) 
RERI (95% CL)  2.7 (0.7, 4.7)    ‐3.1 (‐9.0, 2.9)    0.5 (‐0.4, 1.3) 
           
                             
Located in designated 
HPSA 
                           
Yes  10/22  Ref  0/4  2.4 (0.7, 8.3)    6/9  Ref  4/12  2.8 (0.7, 11.3)    3/13  Ref  7/12  0.4 (0.1, 1.3) 
No  32/134  1.4 (0.7, 2.8)  4/38  3.2 (1.5, 7.0)    30/96  1.9 (0.6, 6.4)  6/56  4.7 (1.4, 16..2)    10/53  0.8 (0.4, 1.7)  26/118  1.0 (0.5, 2.1) 
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    n=206  n=1733    n=189  n=1146   
Child Characteristics               
Sex  Female 27 626 0.04 46  399 0.12
  Male  179 1107 0.16 143  747 0.19
Race  Non‐Hispanic White 118 1116 0.11 179  1106 0.16
  Non‐Hispanic Black 73 491 0.15 7  34 0.21
  Other 14 126 0.11 2  6 0.33
Firstborn  No  96 1121 0.09 101  728 0.14
  Yes  110 612 0.18 86  416 0.21
Previously diagnosed autism  Yes  158 136 
  No  48 53 
Comorbid ID  Yes (IQ <= 70) 91 70 
  No  104 56 
  Missing 11 63 
Family Characteristics     
Maternal education  < High school 30 396 0.08 31  298 0.10
  High school degree 104 969 0.11 127  736 0.17
  College degree 71 367 0.19 28  104 0.27
Maternal age (years)  22 or younger 37 438 0.08 49  402 0.12
  23‐34 141 1075 0.13 117  646 0.18
  35 or older 28 220 0.13 23  97 0.24
Married  No  60 544 0.11 51  309 0.17
  Yes  146 1189 0.12 137  832 0.16
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    n=206  n=1733    n=189  n=1146   
Smoking in pregnancy  No  178 1404 0.13 140  805 0.17
  Yes  27 327 0.08 47  328 0.14
Census Tract Characteristics     
Urban/rural  100% Rural 21 297 0.07 70  505 0.14
  Mixed 104 823 0.13 76  459 0.17
  100% Urban 81 613 0.13 31  132 0.23
Median household income 
($/year) 
<= 20,000 25 234 0.11 84  544 0.15
  20,000<=30,000 91 737 0.12 66  435 0.15
  30,000<=40,000 54 573 0.09 26  110 0.24
  > 40,000 36 188 0.19 1  7 0.14
Study Design     
Surveillance Year  2000 0 0 81  603 0.13
  2002 87 914 0.10 108  543 0.20


















    G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD 
Acetaldehyde    784.1 1.1 559.5 1.4 630.5 1.4  488.7 1.5 208.6 2.1 231.1 2.1
Acrolein    110.1 1.1 85.4 1.2 93.5 1.2  92.8 1.4 52.4 1.5 56.1 1.6
Acrylonitrile    0.9 2.0 0.7 2.2 0.8 2.1  1.9 4.4 0.3 4.4 0.4 5.0
Arsenic Compounds    0.22 1.6 0.13 2.0 0.15 2.0  0.11 2.0 0.02 6.5 0.03 6.3
Benzene  480  1523.1 1.1 1066.4 1.2 1209.7 1.3  1387.6 1.3 790.2 1.3 845.6 1.4
Beryllium Compounds    0.035 1.7 0.018 2.1 0.023 2.1  0.012 1.7 0.002 2.6 0.002 3.0
1,3‐Butadiene    85.9 1.3 37.8 1.7 50.6 1.8  81.7 1.6 20.9 2.0 24.6 2.3
Cadmium Compounds    0.084 1.7 0.047 1.8 0.058 1.9  0.046 2.1 0.010 3.6 0.012 3.8
Carbon Tetrachloride  880  880.3 1.0 880.4 1.0 880.3 1.0  880.3 1.0 880.1 1.0 880.1 1.0
Chloroform  83  85.9 1.0 84.9 1.0 85.2 1.0  87.8 1.1 84.4 1.0 84.8 1.1
Chromium Compounds    3.4 3.0 1.8 2.5 2.3 2.8  1.0 5.6 0.1 5.1 0.1 6.0
Coke Oven Emissions 2    0% 0% 0%   38% 20% 22%
1,3‐Dichloropropene    80.2 1.2 33.8 1.7 45.9 1.8  71.8 1.6 13.6 2.5 16.7 2.8
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    G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD 
Diesel Particulate Matter    1788.3 1.2 1358.6 1.2 1497.3 1.3  2792.7 1.7 1111.3 1.7 1241.7 1.8
Ethylbenzene    485.9 1.2 242.6 1.6 310.2 1.7  360.0 1.5 80.2 2.4 96.1 2.6
Ethylene Dibromide  7.7  7.7 1.0 7.7 1.0 7.7 1.0  7.7 1.0 7.7 1.0 7.7 1.0
Ethylene Dichloride  61  61.2 1.0 61.3 1.0 61.2 1.0  61.1 1.0 61.0 1.0 61.0 1.0
Ethylene Oxide    8.9 1.9 2.9 1.9 4.3 2.3  6.1 4.0 0.5 6.7 0.6 7.6
Formaldehyde  250  1090.4 1.1 912.7 1.3 972.0 1.3  936.9 1.3 590.4 1.3 624.2 1.4
Hexachlorobenzene  0.093  0.093 1.0 0.093 1.0 0.093 1.0  0.093 1.0 0.093 1.0 0.093 1.0
Hexane    566.3 1.2 264.5 1.6 346.2 1.7  547.6 1.6 119.7 2.5 143.7 2.8
Hydrazine    15 E‐5 3.9 4 E‐5 3.6 6 E‐5 4.3  48 E‐5 9.4 0 E‐5 87.8 1 E‐5 95.2
Lead Compounds    3.17 1.6 2.09 1.9 2.42 1.9  1.09 2.7 0.24 3.5 0.29 3.7
Manganese Compounds    5.8 1.7 4.9 2.3 5.2 2.1  3.0 3.8 0.4 4.4 0.6 4.9
Mercury Compounds    0.309 1.3 0.224 1.7 0.251 1.6  0.187 1.7 0.051 2.9 0.060 3.0
Methyl tert‐butyl ether (MTBE)    102.3 1.3 50.2 1.6 64.6 1.7  126.9 1.7 33.9 2.5 39.7 2.6
Methylene Chloride  150  679.1 1.9 476.0 1.8 539.8 1.9  338.3 1.3 188.6 1.2 202.3 1.3
Nickel Compounds    1.9 1.6 0.8 1.9 1.1 2.0  1.5 7.4 0.1 4.9 0.2 6.3
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    G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD  G Mean  G SD 
Perchloroethylene  140  288.9 1.1 198.9 1.2 227.0 1.3  258.9 1.3 162.9 1.2 172.2 1.3
Polychlorinated Biphenyls  0.38  0.380 1.0 0.380 1.0 0.380 1.0  0.380 1.0 0.380 1.0 0.380 1.0
Polycyclic Aromatic 
Hydrocarbons Group (PAH7) 
  6.7 2.7 3.4 1.8 4.3 2.3  3.0 1.4 1.2 1.6 1.4 1.7
Propionaldehyde    222.3 1.2 155.5 1.4 176.5 1.4  105.0 1.4 47.4 2.0 52.1 2.0
Propylene Dichloride    0.056 2.0 0.038 2.2 0.044 2.2  0.041 1.8 0.011 2.9 0.013 3.0
Quinoline    0.0025 6.2 0.0010 3.5 0.0014 4.7  0.0101 19.5 0.0001 55.4 0.0001 68.1
Styrene    48.4 1.7 15.8 2.1 23.4 2.3  58.4 2.3 7.5 3.7 9.6 4.2
1,1,2,2‐Tetrachloroethane    0.53 2.3 0.37 2.7 0.42 2.6  0.20 1.8 0.08 2.9 0.09 2.9
Toluene    3202.7 1.2 1672.3 1.7 2104.5 1.7  2604.9 1.7 584.0 2.3 699.2 2.6
Trichloroethylene  81  129.1 1.2 113.6 1.4 118.8 1.3  119.0 1.2 87.0 1.1 90.3 1.2
Vinyl Chloride    1.24 2.2 0.96 2.3 1.05 2.3  1.31 4.0 0.26 3.6 0.32 4.1









  Unit change1  Urban/Rural    State    All 
  (ng/m3) 100% Rural Mixed 100% Urban  NC WV
Total sample (cases)    881 (89) 1446 (177) 850 (108)  1931 (201) 1246 (173) 3177 (374)
Acetaldehyde  756 vs. 238  1.3 (0.6, 2.9)  1.3 (0.5, 3.6)  0.8 (0.3, 2.4)    1.4 (0.5, 4.1)  1.0 (0.5, 2.1)    1.1 (0.6, 2.3) 
Acrolein  109 vs. 53 1.2 (0.6, 2.5) 1.4 (0.7, 2.6) 0.9 (0.5, 1.9)  1.3 (0.7, 2.7) 1.2 (0.6, 2.2) 1.2 (0.7, 2.1)
Acrylonitrile  1.4 vs. 0.2 0.9 (0.4, 2.0) 1.0 (0.5, 2.4) 0.8 (0.3, 2.5)  0.6 (0.2, 2.4) 1.0 (0.5, 1.8) 0.8 (0.5, 1.5)
Arsenic Compounds  0.21 vs. 0.03 0.9 (0.5, 1.6) 1.2 (0.8, 1.8) 0.9 (0.2, 4.3)  0.9 (0.3, 2.9) 0.9 (0.7, 1.3) 1.0 (0.8, 1.3)
Benzene  1438 s. 742 1.1 (0.6, 2.0) 1.0 (0.5, 1.8) 1.0 (0.5, 1.9)  1.0 (0.5, 1.9) 0.9 (0.5, 1.6) 0.9 (0.5, 1.6)
Beryllium Compounds  0.031 vs. 0.003 0.6 (0.1, 2.5) 1.6 (0.4, 5.9) 2.1 (0.4, 11)  1.1 (0.3, 4.9) 0.9 (0.2, 4.6) 0.9 (0.4, 2.1)
1,3‐Butadiene  79 vs. 18 1.1 (0.4, 3.2) 1.7 (0.7, 4.3) 1.0 (0.3, 3.6)  1.6 (0.5, 4.8) 1.4 (0.6, 3.4) 1.5 (0.7, 3.3)
Cadmium Compounds  0.07 vs. 0.01 1.2 (0.4, 3.5) 0.8 (0.4, 1.9) 1.2 (0.3, 4.7)  1.2 (0.4, 3.2) 0.6 (0.3, 1.6) 1.1 (0.6, 2.0)
Chloroform  90 vs. 831 1.0 (0.9, 1.1) 1.0 (0.9, 1.1) 1.0 (0.9, 1.1)  1.0 (0.9, 1.1) 1.0 (0.9, 1.1) 1.0 (0.9, 1.1)
Chromium Compounds  3.4 vs. 0.2 1.1 (0.3, 4.2) 1.4 (0.5, 4.4) 0.7 (0.1, 3.6)  0.7 (0.2, 2.9) 2.0 (0.7, 5.4) 1.2 (0.6, 2.5)
Coke Oven Emissions 2  Any vs. None 1.4 (0.7, 2.7) 0.9 (0.5, 1.7) 1.8 (0.8, 4.2)  NE 1.2 (0.8, 1.7) 1.2 (0.8, 1.8)
1,3‐Dichloropropene  71 vs. 14 1.7 (0.5, 6.4) 1.8 (0.5, 5.9) 0.9 (0.2, 3.5)  1.2 (0.3, 4.2) 1.7 (0.5, 5.2) 1.9 (0.8, 4.8)
Diesel Particulate Matter  1844 vs. 1025 0.9 (0.5, 1.6) 1.0 (0.7, 1.6) 0.9 (0.6, 1.5)  1.1 (0.6, 1.9) 1.0 (0.7, 1.5) 1.1 (0.8, 1.5)
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  Unit change1  Urban/Rural    State    All 
  (ng/m3) 100% Rural Mixed 100% Urban  NC WV
Total sample (cases)    881 (89) 1446 (177) 850 (108)  1931 (201) 1246 (173) 3177 (374)
Ethylbenzene  441 vs. 82 0.6 (0.1, 2.3) 1.2 (0.3, 5) 0.9 (0.2, 4.2)  1.5 (0.3, 6.6) 0.5 (0.1, 2.0) 0.7 (0.2, 2.6)
Ethylene Oxide  8.4 vs. 0.5 0.8 (0.3, 2.4) 1.0 (0.5, 2.1) 1.0 (0.3, 3.2)  0.5 (0.1, 1.9) 1.2 (0.6, 2.2) 1.0 (0.6, 1.6)
Formaldehyde  1074 vs. 589 1.0 (0.6, 1.7) 1.0 (0.6, 1.7) 0.9 (0.5, 1.7)  1.1 (0.6, 1.7) 0.9 (0.5, 1.5) 0.9 (0.6, 1.4)
Hexane  523 vs. 120 1.4 (0.4, 4.9) 1.1 (0.3, 3.3) 1.0 (0.3, 3.6)  1.1 (0.3, 4.2) 0.9 (0.3, 2.5) 1.0 (0.4, 2.8)
Hydrazine  2.4 E‐4vs. 3.4 E‐6 0.5 (0.2, 1.1) 0.8 (0.4, 1.4) 0.4 (0.1, 1.3)  1.0 (0.3, 3.7) 0.7 (0.4, 1.1) 0.6 (0.4, 0.9)
Lead Compounds  3.1 vs. 0.3 0.9 (0.3, 2.7) 0.7 (0.3, 1.5) 0.3 (0.1, 1.3)  0.6 (0.2, 1.5) 0.9 (0.5, 1.9) 0.7 (0.4, 1.1)
Manganese Compounds  7.1 vs. 0.4 1.2 (0.5, 3.3) 0.7 (0.3, 1.6) 0.6 (0.1, 3.4)  0.7 (0.2, 2.6) 0.8 (0.4, 1.8) 0.8 (0.4, 1.4)
Mercury Compounds  0.3 vs. 0.1 1.2 (0.5, 3.1) 0.9 (0.4, 2.2) 1.0 (0.3, 3.2)  0.9 (0.4, 2.2) 1.1 (0.5, 2.4) 1.2 (0.7, 2.1)
Methyl tert‐butyl ether 
(MTBE) 
100 vs. 30 1.6 (0.7, 3.6) 0.8 (0.4, 1.7) 0.9 (0.4, 2.3)  0.9 (0.4, 2.1) 1.2 (0.6, 2.2) 0.9 (0.5, 1.5)
Methylene Chloride  640 vs. 183 1.2 (0.4, 3.3) 1.2 (0.6, 2.5) 1.9 (0.8, 4.7)  1.5 (0.6, 3.3) 1.0 (0.4, 3.0) 1.4 (0.7, 2.5)
Nickel Compounds  1.7 vs. 0.1 1.2 (0.4, 3.4) 0.9 (0.4, 2.0) 1.8 (0.6, 4.9)  0.8 (0.2, 3.3) 0.9 (0.4, 1.8) 1.1 (0.6, 1.9)
Perchloroethylene  271 vs. 155 1.1 (0.6, 2.0) 1.2 (0.7, 2.0) 1.0 (0.6, 1.7)  1.1 (0.7, 1.9) 1.1 (0.6, 1.8) 1.1 (0.7, 1.7)
Polycyclic Aromatic 
Hydrocarbons Group (PAH7) 
4.9 vs. 1.2 0.7 (0.2, 3.2) 0.3 (0.1, 1.0) 1.0 (0.5, 1.9)  0.9 (0.4, 1.8) 0.9 (0.2, 3.6) 0.7 (0.4, 1.3)
Propionaldehyde  208 vs. 56 1.2 (0.4, 3.3) 1.3 (0.5, 3.6) 1.1 (0.4, 3.5)  1.1 (0.4, 3.4) 1.2 (0.5, 3.1) 1.5 (0.6, 3.6)
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  Unit change1  Urban/Rural    State    All 
  (ng/m3) 100% Rural Mixed 100% Urban  NC WV
Total sample (cases)    881 (89) 1446 (177) 850 (108)  1931 (201) 1246 (173) 3177 (374)
Propylene Dichloride  0.08 vs. 0.01 0.7 (0.2, 3.2) 0.9 (0.2, 3.2) 0.8 (0.2, 3.9)  0.8 (0.2, 3.7) 0.6 (0.2, 2.4) 0.8 (0.3, 2.3)
Quinoline  0.0051 vs. 0.0001 1.5 (0.7, 3.3) 1.1 (0.6, 2.1) 2.1 (0.8, 5.6)  2.1 (0.4, 11.2) 1.3 (0.8, 2.1) 1.4 (1.0, 2.2)
Styrene  41 vs. 5 0.8 (0.2, 2.7) 1.1 (0.5, 2.8) 2.0 (0.6, 6.1)  2.0 (0.6, 6.9) 1.6 (0.8, 3.2) 1.8 (1.0, 3.1)
1,1,2,2‐Tetrachloroethane  0.8 vs. 0.1 1.0 (0.2, 5.6) 1.2 (0.4, 3.8) 0.8 (0.2, 3.5)  0.7 (0.1, 3.2) 1.9 (0.5, 7.3) 1.2 (0.4, 3.2)
Toluene  3018 vs. 582 0.4 (0.1, 2.8) 0.3 (0.1, 1.6) 0.6 (0.1, 3.5)  0.5 (0.1, 3.0) 0.6 (0.1, 3.4) 0.4 (0.1, 1.3)
Trichloroethylene  129 vs. 85 1.1 (0.7, 1.6) 1.1 (0.8, 1.5) 1.0 (0.7, 1.5)  1.1 (0.8, 1.5) 1.0 (0.7, 1.5) 1.0 (0.8, 1.3)
Vinyl Chloride  2.0 vs. 0.3 0.9 (0.3, 3.3) 0.8 (0.3, 2.5) 1.3 (0.3, 5)  0.8 (0.2, 3.3) 0.9 (0.4, 2.4) 0.9 (0.4, 2.0)
































































































































































































































































































































































































































































































































































































































































































Automatic software geocoding1  168  76%  241  77% 
Interactive software geocoding2  25  11%  32  10% 
Melissa Data Address Lookup7  8  4%  21  7% 
Interactive review of several maps8  3  1%  5  2% 
Credit database search 9  7  3%  3  1% 
































































































Mean  StDev  Mean  StDev 
Number of primary care physicians within 5 
miles  48  52  33  37 
Number of specialist physicians within 5 
miles  34  42  18  22 
Number of psychologists within 5 miles 33 41 25  32
Number of primary care physicians within 
20 miles  246  160  131  102 
Number of specialist physicians within 20 
miles  161  124  67  77 
Number of psychologists within 20 miles 156 130 71  70
Distance to nearest primary care physician 
(miles)  2  2  3  3 
Distance to nearest specialist physician 
(miles)  3  3  6  6 
Distance to nearest psychologist (miles) 3 3 6  5
Distance to nearest teaching hospital (miles) 17 15 30  10
Distance to nearest TEACCH (miles) 17 11 20  10








Mean  StDev  Mean  StDev 
Number of primary care physicians within 5 
miles  17  33  62  51 
Number of specialist physicians within 5 
miles  11  25  43  42 
Number of psychologists within 5 miles  11 27 43  42
Number of primary care physicians within 
20 miles  191  129  252  168 
Number of specialist physicians within 20 
miles  121  104  164  130 
Number of psychologists within 20 miles  115 97 160  138
Distance to nearest primary care physician 
(miles)  3  3  1  1 
Distance to nearest specialist physician 
(miles)  5  4  2  2 
Distance to nearest psychologist (miles)  6 4 2  2
Distance to nearest teaching hospital (miles)  23 16 17  14
Distance to nearest TEACCH (miles)  20 13 16  9














_________    20-90 miles 
- - - - - - - -   < 20 miles 
_________    20-90 miles 
- - - - - - - -   < 20 miles 




_________    20-90 miles 
- - - - - - - -   < 20 miles 
_________    20-90 miles 
- - - - - - - -   < 20 miles 





















Acetaldehyde  0 1 0  1 0 0
Acrolein  0 1 0  1 0 0
Acrylonitrile  0 1 0  0 1 0
Arsenic Compounds  1 1 1  0 0 0
Benzene  0 1 0  0 1 0
Beryllium Compounds  0 1 1  0 0 0
1,3‐Butadiene  0 1 0  1 0 1
Cadmium Compounds  0 1 1  0 0 1
Chloroform  0 1 0  1 0 1
Chromium Compounds  0 1 1  0 0 0
Coke Oven Emissions  0 0 0  0 1 0
Dichloropropene  0 0 0  1 0 0
Diesel Particulate Matter  0 0 0  1 0 0
Ethylene Oxide  0 0 0  0 1 0
Ethylbenzene  0 1 0  1 0 1


















Hexane  0 1 0  0 1 0
Hydrazine  0 1 0  1 0 1
Lead Compounds  1 1 1  0 0 0
Manganese Compounds  1 1 1  0 0 0
Mercury Compounds  1 1 1  0 0 0
Methylene Chloride  0 1 0  0 1 0
Methyl tert‐butyl ether (MTBE)  0 1 0  0 1 0
Nickel Compounds  0 1 1  0 0 0
Polycyclic Aromatic Hydrocarbons 
Group (PAH7) 
1 0 0  1 0 1
Perchloroethylene  0 1 0  1 0 0
Propylene Dichloride  0 0 0  0 1 0
Propionaldehyde  0 0 0  0 0 0
Quinoline  0 0 0  1 0 1
Styrene  0 1 1  0 0 1
1,1,2,2‐Tetrachloroethane  0 0 0  1 0 0
Toluene  1 0 0  1 0 1
Trichloroethylene  0 1 0  0 1 0
Vinyl Chloride  0 1 0  0 1 0













Unadjusted ORs (95% CL) from categoric coding, compared to 14‐53 ng/m3:  53‐74  1.0 (0.7, 1.4)   
    4‐95  1.2 (0.8, 1.8) 
    95‐109  1.5 (1.0, 2.3) 






































Unadjusted ORs (95% CL) from categoric coding, compared to 4‐18 ng/m3s:  18‐32  1.3 (0.9, 1.9)   
    32‐55  1.3 (1.0, 1.9) 
    55‐78  1.5 (1.0, 2.2) 






































A  B  C  D  E 
EPA, neuro, 
placenta  Indoor only  EPA only  Indoor, EPA, neuro  All one group 
Acetaldehyde  1.4 (0.5, 3.7)  1.2 (0.4, 3)  1.3 (0.5, 3.3)  1.2 (0.4, 3.5)  1.2 (0.5, 3.1) 
Acrolein  1.3 (0.7, 2.6)  1.2 (0.7, 2.3)  1.3 (0.7, 2.4)  1.3 (0.6, 2.5)  1.2 (0.7, 2.3) 
Acrylonitrile  0.6 (0.2, 2.4)  0.6 (0.2, 2.3)  0.6 (0.1, 2.3)  0.6 (0.1, 2.3)  0.6 (0.2, 2.3) 
Arsenic Compounds  1 (0.3, 2.9)  1.1 (0.4, 3.2)  1.1 (0.4, 3.2)  1 (0.3, 3)  1.2 (0.4, 3.2) 
Benzene  1 (0.5, 1.9)  1 (0.6, 1.9)  1 (0.5, 1.9)  1 (0.5, 1.9)  1.1 (0.6, 1.9) 
Beryllium Compounds  1.1 (0.3, 4.8)  1 (0.3, 4.3)  1 (0.3, 4.3)  1.1 (0.3, 4.4)  1.1 (0.3, 4.4) 
1,3‐Butadiene  1.5 (0.5, 4.6)  1.5 (0.5, 4.5)  1.4 (0.5, 4.3)  1.5 (0.5, 4.8)  1.4 (0.5, 4.1) 
Cadmium Compounds  1.1 (0.5, 2.8)  1.1 (0.5, 2.8)  1.1 (0.4, 2.6)  1.2 (0.4, 3.2)  1.1 (0.4, 2.6) 
Chloroform  1 (1, 1)  1 (1, 1)  1 (1, 1)  1 (1, 1)  1 (1, 1) 
Chromium Compounds  0.8 (0.2, 2.8)  0.6 (0.2, 2)  0.6 (0.2, 2)  0.7 (0.2, 2.5)  0.6 (0.2, 2) 
1,3‐Dichloropropene  1.2 (0.4, 4)  1.2 (0.4, 3.9)  1.3 (0.4, 4.2)  1.3 (0.4, 4.4)  1.2 (0.4, 4) 
Diesel Particulate Matter  1.1 (0.6, 1.9)  1.1 (0.6, 1.8)  1.1 (0.7, 1.9)  1.1 (0.6, 2)  1.1 (0.6, 1.8) 




A  B  C  D  E 
EPA, neuro, 
placenta  Indoor only  EPA only  Indoor, EPA, neuro  All one group 
Ethylene Oxide  0.5 (0.1, 1.9)  0.5 (0.1, 1.9)  0.5 (0.1, 1.9)  0.5 (0.1, 2)  0.5 (0.2, 1.9) 
Formaldehyde  1.1 (0.7, 1.7)  1 (0.6, 1.6)  1 (0.6, 1.6)  1 (0.6, 1.7)  1 (0.6, 1.6) 
Hexane  1.1 (0.3, 4.2)  1.2 (0.3, 4.1)  1.1 (0.3, 4.1)  1.1 (0.3, 4.2)  1.2 (0.4, 4.2) 
Hydrazine  1 (0.3, 3.7)  0.9 (0.3, 3.5)  0.9 (0.3, 3.4)  1 (0.3, 3.6)  0.9 (0.2, 3.4) 
Lead Compounds  0.6 (0.2, 1.5)  0.7 (0.3, 1.6)  0.6 (0.3, 1.6)  0.6 (0.2, 1.5)  0.7 (0.3, 1.6) 
Manganese Compounds  0.7 (0.2, 2.5)  0.8 (0.3, 2.6)  0.8 (0.3, 2.7)  0.7 (0.2, 2.5)  0.8 (0.3, 2.6) 
Mercury Compounds  0.9 (0.4, 2.2)  1 (0.4, 2.2)  1 (0.4, 2.3)  0.9 (0.4, 2.2)  1 (0.5, 2.3) 
Methyl tert‐butyl ether (MTBE)  0.8 (0.3, 2.1)  0.8 (0.3, 2.1)  0.8 (0.3, 2)  0.8 (0.3, 2.1)  0.9 (0.4, 2.1) 
Methylene Chloride  1.4 (0.7, 3.1)  1.4 (0.6, 2.9)  1.4 (0.6, 2.9)  1.4 (0.6, 2.9)  1.4 (0.7, 3) 
Nickel Compounds  0.8 (0.2, 3.2)  0.8 (0.2, 3.2)  0.8 (0.2, 3.3)  0.8 (0.2, 3.3)  0.8 (0.2, 3.2) 
Perchloroethylene  1.1 (0.7, 1.8)  1 (0.6, 1.6)  1.1 (0.7, 1.8)  1.1 (0.6, 1.8)  1 (0.7, 1.7) 
Polycyclic Aromatic 
Hydrocarbons Group (PAH7)  0.9 (0.5, 1.7)  1 (0.5, 1.8)  1 (0.5, 1.8)  0.9 (0.5, 1.8)  1 (0.5, 1.8) 
Propionaldehyde  1.2 (0.4, 3.6)  1.2 (0.4, 3.4)  1.1 (0.4, 3.3)  1.1 (0.4, 3.4)  1.2 (0.4, 3.5) 
Propylene Dichloride  0.8 (0.2, 3.6)  1 (0.3, 4.2)  1 (0.2, 4)  1 (0.2, 4)  1 (0.3, 4.2) 




A  B  C  D  E 
EPA, neuro, 
placenta  Indoor only  EPA only  Indoor, EPA, neuro  All one group 
Styrene  2 (0.7, 6.3)  1.9 (0.7, 5.5)  1.7 (0.6, 5.1)  1.9 (0.6, 6.2)  1.8 (0.6, 5.3) 
1,1,2,2‐Tetrachloroethane  0.7 (0.2, 2.9)  0.6 (0.2, 2.5)  0.7 (0.2, 3.1)  0.7 (0.2, 3.2)  0.6 (0.2, 2.5) 
Toluene  0.5 (0.1, 2.9)  0.9 (0.2, 3.4)  0.9 (0.2, 3.3)  0.7 (0.2, 3.2)  0.8 (0.2, 3.1) 
Trichloroethylene  1.1 (0.8, 1.5)  1.1 (0.8, 1.5)  1.1 (0.8, 1.5)  1.1 (0.8, 1.5)  1.1 (0.8, 1.5) 
Vinyl Chloride  0.8 (0.2, 3.2)  0.8 (0.2, 3.2)  0.7 (0.2, 3.1)  0.7 (0.2, 3.1)  0.8 (0.2, 3.2) 














































































































































































































Male  Female  AU + ID  AU no ID 
Sample number (cases)  2108 (304) 1069 (70) 2956 (153)  3024 (221)
Acetaldehyde  1.1 (0.6, 2.4) 1.1 (0.4, 3.3) 1.1 (0.4, 2.7)  1.1 (0.5, 2.4)
Acrolein  1.3 (0.7, 2.3) 1 (0.5, 2.1) 0.9 (0.5, 1.8)  1.3 (0.7, 2.4)
Acrylonitrile  0.7 (0.4, 1.3) 1.2 (0.4, 3.2) 1.3 (0.6, 2.9)  0.6 (0.3, 1.3)
Arsenic Compounds  1.1 (0.8, 1.4) 0.9 (0.5, 1.7) 1 (0.6, 1.5)  1 (0.7, 1.4)
Benzene  0.9 (0.5, 1.7) 1 (0.5, 1.9) 1.1 (0.6, 2)  0.9 (0.5, 1.6)
Beryllium Compounds  0.8 (0.3, 2.2) 1 (0.2, 4.9) 1.1 (0.3, 3.4)  0.8 (0.3, 2.3)
1,3‐Butadiene  1.5 (0.7, 3.4) 0.9 (0.3, 2.9) 1.2 (0.4, 3)  1.5 (0.6, 3.5)
Cadmium Compounds  1.3 (0.7, 2.5) 0.6 (0.2, 1.9) 1.3 (0.6, 2.8)  1 (0.5, 1.9)
Chloroform   1 (0.9, 1.1) 1 (0.9, 1.1) 1 (0.9, 1.1)  1 (0.9, 1.1)
Chromium Compounds 1.1 (0.5, 2.5) 1 (0.3, 4.2) 1.1 (0.4, 3.1)  1.2 (0.5, 3)
Coke Oven Emissions  1.2 (0.8, 1.9) 1.1 (0.5, 2.6) 1.9 (1.1, 3.2)  1.0 (0.6, 1.6)
1,3‐Dichloropropene  1.7 (0.6, 4.7) 1.8 (0.5, 7) 1 (0.3, 3.1)  2.2 (0.8, 6.2)
Diesel Particulate Matter  1 (0.7, 1.5) 1.2 (0.7, 2) 0.9 (0.6, 1.5)  1 (0.7, 1.5)
Ethylbenzene  0.8 (0.2, 3.2) 0.8 (0.2, 3.4) 1.1 (0.3, 4.6)  0.6 (0.2, 2.5)
Ethylene Oxide  1 (0.6, 1.7) 1.2 (0.5, 2.9) 0.8 (0.4, 1.7)  1.1 (0.6, 1.9)
Formaldehyde  1 (0.6, 1.6) 0.8 (0.5, 1.5) 0.9 (0.6, 1.6)  0.9 (0.6, 1.5)
Hexane  0.9 (0.3, 2.6) 1.4 (0.4, 4.5) 1 (0.3, 3)  1.1 (0.4, 3.2)
Hydrazine  0.6 (0.4, 1) 0.5 (0.2, 1.2) 0.5 (0.3, 1)  0.6 (0.4, 1)
Lead Compounds  0.7 (0.4, 1.3) 0.7 (0.2, 2.2) 0.5 (0.2, 1)  0.9 (0.5, 1.7)
Manganese Compounds  0.8 (0.4, 1.6) 0.8 (0.2, 2.7) 0.6 (0.2, 1.3)  1 (0.5, 1.9)
Mercury Compounds  1 (0.5, 1.9) 1.8 (0.7, 4.4) 1.7 (0.8, 3.6)  0.9 (0.5, 1.8)




Methylene Chloride  1.2 (0.6, 2.4) 1.3 (0.5, 3.4) 1.7 (0.8, 3.7)  1 (0.5, 2.1)
Nickel Compounds  1.2 (0.6, 2.2) 1 (0.3, 3) 1.3 (0.6, 2.8)  1 (0.5, 2.1)




Propionaldehyde  1.5 (0.6, 3.8) 1 (0.3, 2.9) 1.5 (0.6, 4.2)  1.2 (0.5, 3.1)
Propylene Dichloride  0.7 (0.2, 2.4) 0.7 (0.2, 3.2) 0.6 (0.2, 2.5)  1.1 (0.4, 3.6)
Quinoline  1.4 (0.9, 2.3) 1.5 (0.6, 3.8) 1.4 (0.8, 2.5)  1.4 (0.8, 2.3)
Styrene  2.2 (1.1, 4.1) 0.7 (0.2, 2.6) 1.9 (0.8, 4.2)  1.6 (0.8, 3.2)
1,1,2,2‐Tetrachloroethane  1.6 (0.5, 4.6) 0.7 (0.1, 3.9) 1 (0.3, 3.8)  0.9 (0.3, 2.7)
Toluene  0.3 (0.1, 1.3) 1 (0.2, 5.7) 0.3 (0.1, 1.7)  0.7 (0.2, 3)
Trichloroethylene  1 (0.8, 1.3) 1 (0.7, 1.4) 1 (0.8, 1.4)  1 (0.8, 1.3)
Vinyl Chloride  1 (0.4, 2.3) 0.7 (0.2, 2.7) 0.9 (0.3, 2.8)  0.9 (0.4, 2.3)
Xylenes  1.1 (0.3, 3.4) 1.3 (0.3, 4.9) 1.1 (0.3, 3.6)  1 (0.3, 3.2)
1. Models were run seperately for males and females. 
2. The same control group was used, but cases were subsetted to autism with intellectual disabilities, and 
autism without evidence of intellectual disabilities. 
3. All models adjust for state, surveillance year, and a priori confounders:  race (non‐Hispanic white, black, 
other), maternal education (<HS, HS, college), maternal age (quadratic splines with 3 knots), smoking in 
pregnangy (yes, no), marital status, census tract median household income (quadratic splines with 3 knots), 
urbanicity (quadratic splines with 3 knots), 34 hazardous air pollutants. 
4. All models are two‐stage semi‐Bayes models with a prior residual variance tau2 of 0.209 (6‐fold range) and 
exchangeability predictors of know human developmental neurotoxicant, placental transfer, indoor‐
outdoor pollutant concentration, and confidence level in HAPs model estimate. 
5. Highlights show comparisons for which the point estimates are more than 0.4 different. 
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Appendix K:  Odds Ratios and 95% Confidence Limits for Hazardous Air 
Pollutants and Autism from Semi­Bayes Models for North Carolina and West 
Virginia for Different Case Groups:  Children with a Previous Autism 
Diagnosis, and All Children with Surveillance­Confirmed Autism 
Case Group  AU PvDx  All AU 
Sample (Cases) 3082 (279) 3177 (374) 
Acetaldehyde  1.1 (0.5, 2.5) 1.1 (0.6, 2.3) 
Acrolein  1.4 (0.8, 2.5) 1.2 (0.7, 2.1) 
Acrylonitrile  1 (0.5, 1.9) 0.8 (0.5, 1.5) 
Arsenic Compounds  1 (0.8, 1.4) 1 (0.8, 1.3) 
Benzene  1 (0.6, 1.8) 0.9 (0.5, 1.6) 
Beryllium Compounds  1 (0.4, 2.5) 0.9 (0.4, 2.1) 
1,3‐Butadiene  1.2 (0.5, 2.9) 1.5 (0.7, 3.3) 
Cadmium Compounds  0.9 (0.5, 1.6) 1.1 (0.6, 2) 
Chloroform  1 (0.9, 1.1) 1 (0.9, 1.1) 
Chromium Compounds 1.4 (0.6, 3.1) 1.2 (0.6, 2.5) 
Coke Oven Emissions  1.2 (0.8, 1.9) 1.2 (0.8, 1.8) 
1,3‐Dichloropropene  1.7 (0.6, 4.6) 1.9 (0.8, 4.8) 
Diesel Particulate Matter 1.1 (0.7, 1.5) 1.1 (0.8, 1.5) 
Ethylbenzene  0.6 (0.2, 2.4) 0.7 (0.2, 2.6) 
Ethylene Oxide  0.8 (0.5, 1.5) 1 (0.6, 1.6) 
Formaldehyde  0.9 (0.5, 1.4) 0.9 (0.6, 1.4) 
Hexane  1.1 (0.4, 3.1) 1 (0.4, 2.8) 
Hydrazine  0.6 (0.4, 1) 0.6 (0.4, 0.9) 
Lead Compounds  0.6 (0.3, 1.1) 0.7 (0.4, 1.1) 
Manganese Compounds 0.8 (0.4, 1.6) 0.8 (0.4, 1.4) 
Mercury Compounds  1.8 (1, 3.3) 1.2 (0.7, 2.1) 
Methyl tert‐butyl ether (MTBE) 1 (0.6, 1.9) 0.9 (0.5, 1.5) 
Methylene Chloride  1.2 (0.6, 2.3) 1.4 (0.7, 2.5) 
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Nickel Compounds  0.9 (0.5, 1.8) 1.1 (0.6, 1.9) 
Perchloroethylene  1.2 (0.8, 2) 1.1 (0.7, 1.7) 
Polycyclic Aromatic 
Hydrocarbons Group (PAH7) 
0.7 (0.4, 1.5) 0.7 (0.4, 1.3) 
Propionaldehyde  1.3 (0.5, 3.2) 1.5 (0.6, 3.6) 
Propylene Dichloride  0.5 (0.2, 1.8) 0.8 (0.3, 2.3) 
Quinoline  1.3 (0.8, 2.1) 1.4 (1, 2.2) 
Styrene  1.5 (0.8, 3) 1.8 (1, 3.1) 
1,1,2,2‐Tetrachloroethane 1.5 (0.5, 4.5) 1.2 (0.4, 3.2) 
Toluene  0.4 (0.1, 1.6) 0.4 (0.1, 1.3) 
Trichloroethylene  1.1 (0.8, 1.4) 1 (0.8, 1.3) 
Vinyl Chloride  0.8 (0.3, 2.1) 0.9 (0.4, 2) 
Xylenes  1.4 (0.4, 4.3) 1.1 (0.4, 3.4) 
1. All models adjust for state, surveillance year, and a priori confounders:  race (non‐Hispanic white, black, 
other), maternal education (<HS, HS, college), maternal age (quadratic splines with 3 knots), smoking in 
pregnangy (yes, no), marital status, census tract median household income (quadratic splines with 3 knots), 
urbanicity (quadratic splines with 3 knots), 34 hazardous air pollutants. 
2. All models are two‐stage semi‐Bayes models with a prior residual variance tau2 of 0.209 (6‐fold range) and 
exchangeability predictors of know human developmental neurotoxicant, placental transfer, indoor‐
outdoor pollutant concentration, and confidence level in HAPs model estimate. 
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Appendix L:  Odds Ratios and 95% Confidence Limits for Hazardous Air 
Pollutants and Autism from Semi­Bayes Models for North Carolina Seperately 
by Year of Birth 
Case Group  Born 1994  Born 1996 
Sample (Cases) 996 (84) 935 (117) 
Acetaldehyde  1.6 (0.5, 5.2) 1 (0.3, 3.3) 
Acrolein  1.5 (0.7, 3.2) 1 (0.5, 2.1) 
Acrylonitrile  0.3 (0.1, 1.4) 1.1 (0.3, 5.1) 
Arsenic Compounds  0.7 (0.2, 2.9) 0.7 (0.2, 3.2) 
Benzene  0.8 (0.4, 1.5) 1.2 (0.6, 2.2) 
Beryllium Compounds  1.6 (0.3, 8.9) 0.9 (0.2, 4.9) 
1,3‐Butadiene  2.6 (0.7, 9.3) 1.1 (0.3, 3.7) 
Cadmium Compounds  1.1 (0.3, 4.5) 1.5 (0.5, 5.2) 
Chloroform  1 (1, 1.1) 1 (0.9, 1.1) 
Chromium Compounds 0.7 (0.1, 4.1) 1.1 (0.2, 5.4) 
1,3‐Dichloropropene  2.3 (0.5, 9.9) 0.7 (0.2, 2.7) 
Diesel Particulate Matter 1.2 (0.6, 2.4) 0.9 (0.5, 1.7) 
Ethylbenzene  2.1 (0.4, 10.2) 1.3 (0.3, 6.2) 
Ethylene Oxide  0.2 (0, 1.4) 1.2 (0.2, 5.9) 
Formaldehyde  1.3 (0.8, 2.3) 1 (0.6, 1.8) 
Hexane  0.6 (0.1, 2.5) 1.4 (0.4, 5.7) 
Hydrazine  2.2 (0.4, 12.7) 0.7 (0.1, 4.1) 
Lead Compounds  0.4 (0.1, 1.3) 0.6 (0.2, 2.1) 
Manganese Compounds 0.2 (0, 1.3) 1.2 (0.3, 5.6) 
Mercury Compounds  0.5 (0.1, 1.5) 1.3 (0.4, 3.7) 
Methyl tert‐butyl ether (MTBE) 0.6 (0.2, 1.6) 1.2 (0.4, 3) 
Methylene Chloride  0.9 (0.3, 2.5) 1.5 (0.6, 3.8) 
Nickel Compounds  0.7 (0.1, 3.8) 1.1 (0.2, 5.5) 
Perchloroethylene  1.3 (0.7, 2.3) 1 (0.5, 1.7) 
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Polycyclic Aromatic 
Hydrocarbons Group (PAH7)  1.2 (0.5, 2.9)  0.7 (0.3, 1.6) 
Propionaldehyde  1.1 (0.3, 3.3) 1.1 (0.3, 3.3) 
Propylene Dichloride  0.4 (0.1, 2.1) 1.1 (0.2, 5.4) 
Quinoline  8 (0.8, 79.2) 0.9 (0.1, 6.1) 
Styrene  1.9 (0.4, 10.3) 2.7 (0.6, 12) 
1,1,2,2‐Tetrachloroethane 1.4 (0.2, 8.6) 0.5 (0.1, 3) 
Toluene  0.8 (0.1, 5.3) 0.6 (0.1, 3.8) 
Trichloroethylene  0.9 (0.6, 1.3) 1.1 (0.8, 1.6) 
Vinyl Chloride  0.5 (0.1, 2.4) 1.1 (0.2, 5) 
Xylenes  1.6 (0.4, 6.6) 1 (0.3, 4.3) 
1. All models adjust for state, surveillance year, and a priori confounders:  race (non‐Hispanic white, black, 
other), maternal education (<HS, HS, college), maternal age (quadratic splines with 3 knots), smoking in 
pregnangy (yes, no), marital status, census tract median household income (quadratic splines with 3 knots), 
urbanicity (quadratic splines with 3 knots), 34 hazardous air pollutants. 
2. All models are two‐stage semi‐Bayes models with a prior residual variance tau2 of 0.209 (6‐fold range) and 
exchangeability predictors of know human developmental neurotoxicant, placental transfer, indoor‐
outdoor pollutant concentration, and confidence level in HAPs model estimate. 
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